Skip to main content
. 2021 Oct 12;6(6):100275. doi: 10.1016/j.esmoop.2021.100275

Figure 3.

Figure 3

The distribution of somatic mutations detected in eight patients with BTC who had available tumor tissue, plasma, and bile samples.

(A) The distribution of matched, bile-specific, and tissue-specific mutations in eight patients. (B) The distribution of matched, plasma-specific, and tissue-specific mutations in eight patients.

BTC, biliary tract cancer; cfDNA, cell-free DNA; Pla, plasma; Tis, tumor tissue.